119 related articles for article (PubMed ID: 6759822)
21. Expression of major histocompatibility complex (MHC) class II antigens and HLA-DR incompatibility.
Oba S; Toma H; Takahashi K; Ota K
Transplant Proc; 1989 Feb; 21(1 Pt 1):323-4. PubMed ID: 2650137
[No Abstract] [Full Text] [Related]
22. HLA class-II immune response genes and products in leprosy.
de Vries RR; van Eden W; Ottenhoff TH
Prog Allergy; 1985; 36():95-113. PubMed ID: 3918314
[No Abstract] [Full Text] [Related]
23. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
[TBL] [Abstract][Full Text] [Related]
24. Levamisole in the treatment of E.N.L. in leprosy.
Dharmendra
Indian J Lepr; 1985; 57(1):1-10. PubMed ID: 3897402
[No Abstract] [Full Text] [Related]
25. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
26. Presence of HLA-D/DR antigens on the membrane of breast tumour cells.
Bernard D; Maurizis JC; Rusé F; Chassagne J; Chollet P; Sauvezie B; de Latour M; Plagne R
Clin Exp Immunol; 1984 Apr; 56(1):215-21. PubMed ID: 6370519
[TBL] [Abstract][Full Text] [Related]
27. Fibronectin in leprosy lesions: observations using monoclonal antibodies to human fibronectin.
Narayanan RB; Bhutani LK; Sharma AK; Nath I
Indian J Lepr; 1984; 56(3):532-9. PubMed ID: 6597212
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells.
Mitra DK; Rajalingam R; Taneja V; Bhattacharyya BC; Mehra NK
Clin Immunol Immunopathol; 1997 Jan; 82(1):60-7. PubMed ID: 9000043
[TBL] [Abstract][Full Text] [Related]
29. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
30. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy.
Kumar S; Naqvi RA; Khanna N; Rao DN
Mol Immunol; 2011 May; 48(9-10):1178-90. PubMed ID: 21453975
[TBL] [Abstract][Full Text] [Related]
31. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
[TBL] [Abstract][Full Text] [Related]
32. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil.
Lavado-Valenzuela R; José Bravo M; Junqueira-Kipnis AP; Ramos de Souza M; Moreno C; Alonso A; Liberman-Kipnis T; da Silva WD; Caballero A
Int J Immunogenet; 2011 Jun; 38(3):255-8. PubMed ID: 21599852
[TBL] [Abstract][Full Text] [Related]
33. Parasitism of antigen presenting cells in hyperbacillary leprosy.
Poulter LW; Collings LA; Tung KS; Waters MF
Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
[TBL] [Abstract][Full Text] [Related]
34. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.
van Eden W; Elferink BG; de Vries RR; Leiker DL; van Rood JJ
Clin Exp Immunol; 1984 Jan; 55(1):140-8. PubMed ID: 6362932
[TBL] [Abstract][Full Text] [Related]
35. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
[TBL] [Abstract][Full Text] [Related]
36. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
37. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
Ottenhoff TH; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
Tissue Antigens; 1984 Jul; 24(1):25-9. PubMed ID: 6592792
[TBL] [Abstract][Full Text] [Related]
38. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
Thole JE; Janson AA; Cornelisse Y; Schreuder GM; Wieles B; Naafs B; de Vries RR; Ottenhoff TH
J Immunol; 1999 Jun; 162(11):6912-8. PubMed ID: 10352313
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of contrasuppressor T lymphocytes in leprosy; induction of Ia antigens with gamma interferon.
González-Amaro R; Baranda L; Abud-Mendoza C; Salazar-González JF; Moncada B; Garcia R; Alcocer-Varela J
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):651-6. PubMed ID: 2828494
[TBL] [Abstract][Full Text] [Related]
40. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
